EUVIMEDEUVIMED entdecken
Crossref

Manganese‐Chelating L‐Serine Nanoarchitectures: Targeting Kidney Injury Molecule‐1 for Reversing Renal Ischemia‐Reperfusion Injury via Senescence Regulation

Huajun Li, Shan Luo, Yisen Wang, Jian Jiang, Hua Dai, Gen Wei, Lei Fan iD, Juqun Xi iD

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.4618875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Huajun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, P. R. China. Hauptthemen laut MEDLINE: Reperfusion Injury, Serine, Hepatitis A Virus Cellular Receptor 1, Manganese. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, High-Level Talent Support Plan and Qinglan Project of Yangzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is a central driver of renal ischemia‐reperfusion (I/R) injury, and developing targeted antioxidant systems against it remains an unmet challenge. Here, we address this challenge by engineering a dual‐functional metal‐ion/L‐serine nanoarchitecture integrating two key components: precise kidney targeting via L‐serine's molecular recognition of the injury biomarker kidney injury molecule‐1 (Kim‐1), and bioinspired antioxidant catalysis through metal‐ion/amino‐acid‐coordinated enzyme mimicry. Through systematic screening of metal ions (Mg 2 + , Ca 2 + , Mn 2 + , Fe 3+ , Co 2 + , Cu 2 + , and Ce 3+ ), we identified Mn‐chelating L‐serine (L‐SerMn) as the optimal nanoarchitecture, displaying robust superoxide dismutase (SOD)‐ and catalase (CAT)‐like activities. Molecular dynamics simulations revealed stronger binding affinity of L‐SerMn to Kim‐1 compared to free L‐serine. In vitro, L‐SerMn protected renal tubular epithelial cells from hypoxia/reoxygenation (H/R)‐induced damage by functioning as a dual SOD/CAT mimic. In vivo, L‐SerMn achieved selective accumulation in injured kidneys via Kim‐1‐mediated targeting, enabling sustained restoration of redox homeostasis that ameliorated renal pathological injury. Mechanistically, L‐SerMn ameliorated renal I/R injury and blocked the acute kidney injury (AKI)‐chronic kidney disease (CKD) transition via suppression of cellular senescence, through regulating the JAK2‐STAT3 and p53 signaling pathways. This work elegantly integrates coordination chemistry and biomimetic enzymology for the rational design of organ‐targeted nanotherapeutics, offering a promising strategy against ischemic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjurySerineHepatitis A Virus Cellular Receptor 1ManganeseKidneyAnimalsHumansCellular SenescenceOxidative Stress

Stichwörter der Autor:innen

Kim‐1‐targeted deliveryantioxidant enzyme mimicscoordination‐driven self‐assemblyrenal ischemia‐reperfusion injurysenescence modulation

Substanzen

SerineHepatitis A Virus Cellular Receptor 1Manganese

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, P. R. China.
  • The Key Laboratory of the Jiangsu Higher Education Institutions For Integrated Traditional Chinese and Western Medicine in Senile Diseases Control (Yangzhou University), Yangzhou, Jiangsu, P. R. China.
  • College of Chemistry and Materials Science, Yangzhou University, Yangzhou, Jiangsu, P. R. China.

ORCID-Profile: Lei Fan, Juqun Xi

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • High-Level Talent Support Plan and Qinglan Project of Yangzhou University
  • Yangzhou Key Research, Development Program (Social Development)

Zitieren

APA

Li, H., Luo, S., Wang, Y., Jiang, J., Dai, H., Wei, G., Fan, L., & Xi, J. (2026). Manganese‐Chelating L‐Serine Nanoarchitectures: Targeting Kidney Injury Molecule‐1 for Reversing Renal Ischemia‐Reperfusion Injury via Senescence Regulation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.4618875

Vancouver

Li H, Luo S, Wang Y, Jiang J, Dai H, Wei G, et al. Manganese‐Chelating L‐Serine Nanoarchitectures: Targeting Kidney Injury Molecule‐1 for Reversing Renal Ischemia‐Reperfusion Injury via Senescence Regulation. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.4618875

BibTeX
@article{Li2026,
  author = {Li, Huajun and Luo, Shan and Wang, Yisen and Jiang, Jian and Dai, Hua and Wei, Gen and Fan, Lei and Xi, Juqun},
  title = {Manganese‐Chelating L‐Serine Nanoarchitectures: Targeting Kidney Injury Molecule‐1 for Reversing Renal Ischemia‐Reperfusion Injury via Senescence Regulation},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.4618875}
}
Kostenlos starten →